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cancer shows the effectiveness and the absence of excess 
toxicity (above the level II) after the CRT with accelerated 
fractionation dose in CBT. It is assumed to analyze the 
dynamics of accumulation of cytogenetic markers in PBL and 
their deviation from the normal distribution in the course and 
after the CRT of cancer patients. 
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Purpose/Objective: Adaptive radiotherapy approaches for 
cervical cancer patients can have different levels of update 
frequency, varying between re-planning halfway along the 
treatment, weekly re-planning and plan of the day 
approaches. We investigated the variation in organ shape 
within a treatment week and the exemplarity of different 
adaptive strategies.  
Materials and Methods: For 8 cervical cancer patients we 
obtained weekly CT scans and daily CBCT scans. The primary 
and nodal GTVs, bladder, rectum, sigmoid, bowelbag were 
delineated in all 215 scans by a radiation oncologist. Six 
patients were classified as mover (>2.5 cm top of uterus 
motion), two as non-mover. In order to assess the 
appropriateness of different adapted PTV concepts, the 
volume of the cervix-uterus CTV that exceed those PTVs was 
calculated for a static PTV based on planning scan, a weekly 
update of the PTV based on weekly CT scan, a PTV of the CT 
scan with a similar bladder filling status, and based on a plan 
of the day (PotD) approach that consists of an empty – half 
full PTV and a half full – full PTV.  
Results: For the commonly used planning strategy that uses 
one planning CT scan with arbitrary bladder volume, up to 
40% of the daily CTV can be outside the PTV during one or 
more fractions of the treatment; for movers with a large 
bladder filling variation, on average 20-25%. Adaptation of 
the PTV by re-planning on a weekly CT scan, or re-planning 
based on a CT scan with similar bladder volume, decreased 
the volume of the daily CTV outside the PTV somewhat 
(Figure). Besides bladder filling also the status of the rectum 
influenced the position. A PTV created with a PotD approach, 
resulted in acceptable small volumes outside the PTV 
(average 2%). For three mover patients the uterus flipped 
backwards for a few days during treatment and a non-mover 
changed into a mover for a few fractions.  
 
Conclusions: We found that re-planning based on weekly 
imaging, although this gives a good idea about organ position 
variability and tumor shrinkage, is not sufficient to reflect 
the full extent of internal organ motion because the patient 
changes daily and often weekly scans are not made at the 
same time point (and organ configuration) as the treatment 
fraction itself. Furthermore, bladder volume-dependent 
cervix-uterus motion models that were prepared in the 
planning phase should be monitored carefully throughout the 
treatment because they can change.  
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Purpose/Objective: To compare the effect of photon and 
carbon-ion radiation on four cell lines with different HPV-
status regarding cell cycle regulation and HPV associated 
protein expression. Hypothesis is that carbon ion radiation 
might overcome radiation resistance of HPV-negative cells or 
cells with integrated HPV. 
Materials and Methods: W12 cell line was derived from a low 
grade cervical lesion by Stanley MA et al. 1989, and is unique 
among HPV16-containing cell lines in carrying its HPV 16 
genome as a multicopy episome. W12 cells contain episomal 
HPV 16 genomes, whereas S12 cells, which derived from the 
W12 line, contain HPV DNA as integrated copies. Caski cells 
have their origin in epidermoid cell cervical cancer and are 
reported to contain an HPV 16 genome as well as sequences 
related to HPV-18. C33A is a HPV-negative human cervical 
cancer derived cell line. Cell cycle analyses were performed 
using flow cytometry (PI staining) 24 h and 48 h after RT with 
2 and 7 Gy using photon RT and 2 GyE and 7 GyE carbon ion 
RT(C12). Expression of pRb and p53 after irradiation with 2 
and 7 Gy were analyzed by flow cytometry using intracellular 
staining comparing the mean fluorescence of 10000 gated 
cells. 
Results: C33A cells (HPV-negative) showed a minimal 
enhanced expression of pRB after RT with photons or C12 (0 
Gy=1.0, 2 Gy=1.09, 7 Gy=1. 4, 2 GyE= 1.3, 7 GyE=1.1). There 
was no effect of photon or C12 irradiation on p53 expression 
in C33A cells. Caski cells (HPV16/18 positive) showed 
increased expression of pRb after photon RT (2 Gy=1.3, 7 
